NEURO-SYS
Biotechnology ResearchView the employees at
NEURO-SYS-
Sarah Lieger In vitro Lab Manager chez NEURO-SYS
-
Simiane-Collongue, Provence-Alpes-Côte d'Azur, France
-
Rising Star
Morgane Bonnafoux ingénieur en biologie-
Greater Marseille Metropolitan Area
-
Rising Star
Angélique Jimenez Ingénieure de recherche chez Neuro-Sys-
Vitrolles, Provence-Alpes-Côte d'Azur, France
-
Rising Star
Clemence Dumas-Croset Student in Master 2 in RAPC (Recherche Animale Préclinique et Clinique) at Université Claude Bernard Lyon 1-
Gardanne, Provence-Alpes-Côte d'Azur, France
-
Rising Star
Dominique Tousten Office Manager chez NEURO-SYS-
Aix-en-Provence, Provence-Alpes-Côte d'Azur, France
-
Top 10%
Overview
Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields. We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. Our expertise: › Alzheimer’s disease (AD) › Parkinson’s disease (PD) › Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease) › Multiple Sclerosis (MS) › Peripheral Neuropathies › Blood Brain Barrier DRUG DEVELOPMENT SERVICES Our experts in drug and pharmaceutical development provide expert guidance on: •The design of your drug discovery development plan (pre-clinical testing in vitro and in vivo models) •The design of your preclinical research programs (in vitro/ in vivo, mode of action) •The preclinical (Pharmacology, PK and ADME) development and early clinical designs (PoC studies) •The writing of research projects, investigator brochures (IB), IMPD, ODD submission (FDA/EMA) in neuro indication
-